University of Patras
Επίπτωση και αντιμετώπιση του καρκινώματος του οισοφάγου στην περιοχή της Δυτικής Ελλάδας: παράγοντες που σχετίζονται με την καλύτερη πρόγνωση
Abstract
dc:descriptionIntroduction. Esophageal cancer represents the 6th leading cause of cancer related death worldwide. It has poor prognosis, different characteristics based on the geographical area and a prevalence that is constantly changing. Squamous cell carcinoma remains the most common histological type, while adenocarcinoma is on the rise in developed countries. It has a higher incidence in men, in elderly, in obese persons, in countries with low socio-economic profile, etc. 5-year survival of up to 40-60% can be achieved among patients undergoing therapeutic esophagectomy without or with low lymph node involvement, mostly in the setting of multidisciplinary treatment protocols. In recent years, cancer in our country remains the second leading cause of death after cardiovascular disease, with esophageal cancer being placed in the fifth position after lung, breast, prostate and colon cancers. Specifically, our clinical experience and evidence of recent years shows that esophageal cancer in Western Greece has increased by up to 4% compared to the past as well as mortality. The aim of the study was to identify the incidence and evaluate the treatment outcome among patients with esophageal cancer treated by primary esophagectomy in Western Greece, as well as to determine the prognostic factors for long term survival. Methods: For the needs of the analysis of esophageal cancer in the region of Western Greece, data were collected from the databases: ELSTAT, Eurostat, OECD, Globocan, European Cancer Information System (ECIS) and the National Cancer Archive (EAN) in our hospital. In order to find the prognostic factors in relation to the surgical treatment, a retrospective analysis of the data of 92 patients who underwent esophagectomy, between the years 1998 - 2017 at the Cardiothoracic Surgery Clinic of our Hospital was performed. Survival time information was collected through telephone calls with patients or their relatives and municipal services. Kaplan Meier and Cox Regression analyses were used to calculate relative survival and to identify prognostic factors. Results: In recent years there has been an increase in esophageal cancer in Western Greece, up to 4% (2018) compared to previous years, with men outnumbering women (80%), older ages (75 and over) being more affected (average age of diagnosis being at 66 years), adenocarcinoma (68%) becoming more frequent than squamous cell carcinoma and mortality having an upward trend. Upfront esophagectomy was carried out in 92 patients via either a left thoraco-abdominal approach (76) or an Ivor Lewis technique (16). Tumors were located at the gastroesophageal junction (52), lower third (31) and middle third (9) of the esophagus. Histologically there were 73 adenocarcinomas and 19 squamous cell carcinomas. Stomach was used for reconstruction in 90 patients. Neck anastomosis was performed in 7 patients. Study endpoints included: mortality, morbidity, and long-term survival. The mortality after esophagectomy was 10.9%, with 29 patients suffering of 49 postoperative complications. Anastomotic dehiscence occurred in 17.4% of the patients and represented the most common cause of death with mortality of 37.5%. Reoperation was necessary in 14 patients. The median long-term survival was 25 months, with survival of 3 and 5 years rising up to 30.5% and 21% respectively. The 5 year survival of 21% reflects the overall worldwide 5 year survival in mixed-stage esophageal carcinomas. Early stage tumors, the absence of lymph node disease, well-differentiated carcinomas, and lymph node ratio ≤ 0.2 were associated with 5-year survival of 82.6%, 81.6%, 83.3%, and 40.4%, respectively. In multivariate analysis, early stage disease (OR: 15.746, 95% CI: 4.32-58.579, p <0.001) and lymph node ratio ≤ 0.2 (OR: 1.700 95% CI: 1.051-2.752, p = 0.031) were statistically associated with better long-term survival. Conclusion: Our results support the role of upfront surgery as treatment of choice in early-stage esophageal carcinomas without or with low nodal involvement. The stage of the disease and lymph nodes ratio (LN ratio) ≤ 0.2 are important independent prognostic factors for long-term survival.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2021
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Maliouki, Marianna
- Μαλιούκη, Μαριάννα
Subjects
dc:subject × 18- Οισοφαγεκτομή
- Επίπτωση
- Οισοφαγικό καρκίνωμα
- Επιβίωση
- Esophagectomy
- Survival
- Esophageal carcinoma
- Early stage
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Χειρουργική
- Άλλες Ιατρικές Επιστήμες
- Ιατρική, άλλοι τομείς
- Clinical Medicine
- Medical and Health Sciences
- Surgery
- Other Medical Sciences
- Medicine, miscellaneous
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/49900